Your search returned 43 results.

Results
	41.	Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). [electronic resource] by Yiu, Z Z N Ashcroft, D M Evans, I McElhone, K Lunt, M Smith, C H Walton, S Murphy, R Reynolds, N J Ormerod, A D Griffiths, C E M Warren, R B Producer: 20200214 In: The British journal of dermatology vol. 180 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review. [electronic resource] by Mason, K J Williams, S Yiu, Z Z N McElhone, K Ashcroft, D M Kleyn, C E Jabbar-Lopez, Z K Owen, C M Reynolds, N J Smith, C H Wilson, N Warren, R B Griffiths, C E M Producer: 20200921 In: The British journal of dermatology vol. 181 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register. [electronic resource] by Iskandar, I Y K Ashcroft, D M Warren, R B Yiu, Z Z N McElhone, K Lunt, M Barker, J N W N Burden, A D Ormerod, A D Reynolds, N J Smith, C H Griffiths, C E M Producer: 20160615 In: The British journal of dermatology vol. 173 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)